Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SCLN [NASD]
SciClone Pharmaceuticals, Inc.
Index- P/E32.47 EPS (ttm)0.15 Insider Own0.10% Shs Outstand62.93M Perf Week-1.02%
Market Cap306.48M Forward P/E7.38 EPS next Y0.66 Insider Trans1.61% Shs Float44.61M Perf Month0.83%
Income9.60M PEG2.30 EPS next Q0.09 Inst Own55.00% Short Float7.20% Perf Quarter2.74%
Sales156.30M P/S1.96 EPS this Y-67.30% Inst Trans-0.02% Short Ratio14.36 Perf Half Y9.68%
Book/sh2.27 P/B2.15 EPS next Y9.09% ROA5.00% Target Price8.25 Perf Year-29.42%
Cash/sh1.34 P/C3.64 EPS next 5Y14.10% ROE6.20% 52W Range3.68 - 7.58 Perf YTD12.99%
Dividend- P/FCF7.23 EPS past 5Y22.20% ROI6.70% 52W High-35.75% Beta1.46
Dividend %- Quick Ratio4.10 Sales past 5Y33.30% Gross Margin85.90% 52W Low32.34% ATR0.14
Employees870 Current Ratio4.50 Sales Q/Q-16.60% Oper. Margin21.60% RSI (14)51.83 Volatility2.11% 3.09%
OptionableYes Debt/Eq0.01 EPS Q/Q-84.20% Profit Margin6.10% Rel Volume0.92 Prev Close4.87
ShortableYes LT Debt/Eq0.00 EarningsJun 17 Payout0.00% Avg Volume223.56K Price4.87
Recom2.50 SMA20-0.54% SMA502.33% SMA200-0.11% Volume205,262 Change0.00%
18-Sep-12Upgrade BWS Financial Hold → Buy $8.25
10-Aug-10Downgrade BWS Financial Buy → Hold $7.25 → $4.50
09-Apr-10Upgrade BWS Financial Hold → Buy $7.25
08-Jul-09Downgrade BWS Financial Buy → Hold $3.25
03-Jun-09Initiated ThinkEquity Buy $5
21-May-09Initiated Rodman & Renshaw Mkt Outperform $5
05-Sep-08Initiated Susquehanna Financial Neutral
10-Jun-13 02:45PM  See How SciClone Pharmaceuticals Ranks Among Analysts' Top Picks With Strong Buyback Activity at Forbes
31-May-13 09:06AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
28-May-13 06:00AM  SciClone to Present at Jefferies 2013 Global Healthcare Conference Marketwired
06:00AM  SciClone to Present at Jefferies 2013 Global Healthcare Conference Marketwire
19-May-13 09:14AM  China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug at Seeking Alpha
16-May-13 06:13PM  4 Healthcare Stock Stories For Thursday Investing Wellness at Wall St. Cheat Sheet
04:00PM  InPlay: SciClone Pharma and Zensun enter into a licensing agreement for novel chronic heart failure drug neucardin for the China market Briefing.com
04:00PM  SciClone Reports Anticipated Financial Results for the First Quarter 2013 Marketwired
04:00PM  SciClone Reports Anticipated Financial Results for the First Quarter 2013 Marketwire
04:00PM  SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market Marketwired
04:00PM  SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market Marketwire
03:33PM  Socially Responsible Investing in Biotech and Pharmaceutical Companies: Expert Portfolio Manager Finny Kuruvilla Discusses His Construction Strategy with The Wall Street Transcript Wall Street Transcript
10:09AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations an EDGAR Online
10-May-13 06:42AM  Income Idea: 2 Undervalued Drug Makers With Rising Gross Profit Margins at Seeking Alpha
02-May-13 11:20AM  Emerging Markets an Area of Opportunity for Global Generic Players: An Expert Analyst Gives His Take on the Generic Drug Space Wall Street Transcript
08-Apr-13 06:08AM  SciClone appoints PricewaterhouseCoopers as independent accounting firm theflyonthewall.com
06:00AM  SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting Firm Marketwired
06:00AM  SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting Firm Marketwire
07-Apr-13 11:17PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements EDGAR Online
05-Apr-13 01:04PM  SCICLONE PHARMACEUTICALS INC Financials EDGAR Online Financials
09:19AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Statement EDGAR Online
01-Apr-13 09:10PM  SciClone Pharmaceuticals Management Discusses 2012 Results - Earnings Call Transcript at Seeking Alpha
08:32PM  SciClone Q4 Net Drops Steeply at Motley Fool
05:33PM  SciClone Pharmaceuticals Earnings: Heres Why Shares are Down Now at Wall St. Cheat Sheet
04:30PM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:00PM  SciClone Reports 2012 Financial Results and 2013 Outlook Marketwired
04:00PM  SciClone Reports 2012 Financial Results and 2013 Outlook Marketwire
01:14PM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
10:26AM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report EDGAR Online
10:09AM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report EDGAR Online
06:00AM  SciClone Pharmaceuticals to Report 2012 Financial Results and 2013 Outlook on April 1st Marketwired
06:00AM  SciClone Pharmaceuticals to Report 2012 Financial Results and 2013 Outlook on April 1st Marketwire
22-Mar-13 06:00AM  SciClone Appoints Hong Zhao as Chief Executive Officer, China Operations Marketwired
06:00AM  SciClone Appoints Hong Zhao as Chief Executive Officer, China Operations Marketwire
21-Mar-13 11:05PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
18-Mar-13 02:10PM  Healthcare Sector: High Quality Stocks At A Great Value at TheStreet
14-Mar-13 05:01PM  InPlay: SciClone Pharma provides update on the timing of filing its 2012 annual report on Form 10-K Briefing.com
04:00PM  SciClone Provides Update on the Timing of Filing Its 2012 Annual Report on Form 10-K Marketwire
08-Mar-13 03:08PM  See How SciClone Pharmaceuticals Ranks Among Analysts' Top Picks With Strong Buyback Activity at Forbes
26-Feb-13 02:22PM  4 Stocks Under $10 Moving Higher at TheStreet +6.82%
25-Feb-13 02:01PM  SciClone to Restate Financial Statements at Motley Fool -8.71%
09:58AM  SciClone's Credibility Takes Another Hit; So Will The Stock at Seeking Alpha
22-Feb-13 05:40PM  SciClone restating results, cites revenue errors AP
04:07PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Changes in Registrant EDGAR Online
04:05PM  SciClone to restate financials for 2011, 2012 theflyonthewall.com
04:00PM  SciClone to Restate Financial Statements for 2012 and 2011 Periods Marketwire
11-Feb-13 01:58PM  5 Medical Stock Losers From Last Week With High Short Ratios at Seeking Alpha
04-Feb-13 04:00PM  SciClone to Present at BIO CEO & Investor Conference on February 12th Marketwire
02:49AM  SciClone Pharmaceuticals: A Promising Biotech Stock at Seeking Alpha
30-Jan-13 04:00PM  InPlay: SciClone Pharma announces product promotion agreement renewal with Sanofi (SNY) in China Briefing.com
04:00PM  SciClone Announces Product Promotion Agreement Renewal With Key Industry Parnter Sanofi in China Marketwire
25-Jan-13 04:30PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
14-Jan-13 10:24AM  SciClone Pharma names Simon Li to its board AP
06:05AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
06:00AM  SciClone Announces Appointment of Simon Li to Its Board of Directors Marketwire
11-Jan-13 11:16AM  SCLN Guidance Offers Confidence, Stock Is Cheap, And Breaking Out Technically at Seeking Alpha
10-Jan-13 01:34PM  UPDATE 1-FDA recommends lower dose of insomnia drug Ambien, generics at Reuters
07-Jan-13 10:35AM  SciClone 2013 profit forecast tops 2012 view AP
06:29AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors o EDGAR Online
06:04AM  InPlay: SciClone Pharma issues FY13 EPS guidance above consensus; sees FY13 revenues in line with consensus Briefing.com
06:00AM  SciClone Provides Initial 2013 Financial Guidance Marketwire
21-Dec-12 06:12AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
05-Dec-12 06:00AM  SciClone to Present at Oppenheimer 23rd Annual Healthcare Conference on December 13th Marketwire
04-Dec-12 04:25PM  Why SciClone Lost in November at Motley Fool
06:00AM  SciClone Announces New ZADAXIN(R) Anti-Counterfeiting Label Wins Major Industry Award Marketwire
03-Dec-12 09:01AM  Lithium Technologies Names Culhane as CFO in Preparation for IPO at Bloomberg
29-Nov-12 06:00AM  [video] Stocks Under $5: Discount Drug Name at TheStreet
21-Nov-12 12:34PM  2 Stocks That Are Wasting Your Money at Motley Fool
15-Nov-12 01:04PM  SCICLONE PHARMACEUTICALS INC Financials EDGAR Online Financials
12:08AM  SciClone Pharmaceuticals Management Presents at Lazard Capital Markets Healthcare Conference (Transcript) at Seeking Alpha
13-Nov-12 08:25AM  Biotech Industry Experiencing More FDA New Drug Approvals in 2012 Marketwire -5.52%
08:20AM  Biotech Industry Experiencing More FDA New Drug Approvals in 2012 Marketwire
12-Nov-12 09:26AM  New Star Analyst Rankings for SciClone Pharmaceuticals, Inc. StarMine +10.82%
06:00AM  SciClone to Present at Lazard Capital Markets 9th Annual Healthcare Conference on November 14th Marketwire
11-Nov-12 09:25AM  New Star Analyst Rankings for SciClone Pharmaceuticals, Inc. StarMine
10-Nov-12 10:47AM  Sciclone Pharma Slashes Revenue View and 3 Slumping to 52-Week Lows at Wall St. Cheat Sheet
09-Nov-12 04:52PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online -19.35%
04:30PM  SciClone Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
02:54PM  3 Biotechs Rocking Friday's Market at Motley Fool
08:30AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:15AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q3 2012 SciClone Pharmaceuticals, Inc. Earnings Release - Time Not Supplied CCBN
07:01AM  SciClone Board increases reserve for share repurchase program by $10M theflyonthewall.com
06:00AM  SciClone Reports Financial Results for the Third Quarter 2012 and 2012 Outlook Marketwire
08-Nov-12 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2012 and 2012 Outlook on November 9th Marketwire
19-Oct-12 04:06PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online -5.30%
02-Oct-12 10:12AM  4-Star Stocks Poised to Pop: SciClone Pharmaceuticals at Motley Fool
25-Sep-12 08:54AM  PropThink: China-centric SciClone is Creating Growth, Driven by Operating Efficiencies and New Product Licensing Thomson Reuters ONE
22-Sep-12 01:15PM  3 Low PEG Stocks With Positive Momentum at Seeking Alpha
21-Sep-12 11:40AM  PropThink: SciClone Reportedly Exploring Strategic Options Thomson Reuters ONE
20-Sep-12 01:08PM  Affordable Care Act (ACA) is No Longer an Issue for Biotech Stock Valuations: Interview with UBS Investment Bank Expert Analyst Wall Street Transcript
01:05PM  Developments in Hepatitis C, HIV, Rheumatoid Arthritis Therapies Propel Growth in Biotech: Interview with UBS Investment Bank Expert Analyst Wall Street Transcript
11:00AM  3 Stock Upgraded On September 18 To Consider at Seeking Alpha
08:20AM  New Legislation Passed to Help Speed Up FDA Review Process Marketwire
19-Sep-12 06:11PM  Nasdaq stocks posting largest percentage increases AP
01:18PM  Nasdaq stocks posting largest percentage increases AP
18-Sep-12 06:03PM  Nasdaq stocks posting largest percentage increases AP +12.37%
04:55PM  SciClone: China drug price cuts below projections AP
03:55PM  Western Digital Upgraded to Buy and 2 Must-See Upgraded Shares at Wall St. Cheat Sheet
02:22PM  3 Stocks Under $10 Making Big Moves at TheStreet
SciClone Pharmaceuticals, Inc. provides therapies for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders in the People's Republic of China and internationally. Its principal product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant, and as a chemotherapy adjuvant for cancer patients with weakened immune systems. ZADAXIN has approval in approximately 30 countries, which include China, the Pacific Rim, Latin America, eastern Europe, and the Middle East. The company markets and sells ZADAXIN through distribution arrangements, local importers, and distributors. It also markets partnered products in China, including Depakine, an anti-convulsant; Tritace, an ACE inhibitor for the treatment of hypertension; Stilnox, a hypnotic for the short-term treatment of insomnia; and Aggrastat, a cardiology product. The company holds license, promotion, distribution, or marketing agreements for products, such as DC Bead, Loramyc, Abstral, and ondansetron RapidFilm, as well as Rapinyl. SciClone Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blobel FriedhelmPresident & CEOFeb 28Buy3.681,0003,68139,018Apr 08 02:36 PM
Blobel FriedhelmPresident & CEONov 30Buy3.721,0003,72338,018Apr 08 02:36 PM
Blobel FriedhelmPresident & CEOAug 31Buy4.171,0004,16537,018Apr 08 02:36 PM